CCPA Fines Chaayos Rs.50,000 for Default Inclusion of Service Charge in Bills || MP HC: Major Unmarried Daughter Need Not Prove Disability to Claim Maintenance if Unable to Earn || Madras HC: Travel Costs Must be Reimbursed to Independent Special Public Prosecutors || MP HC: Timely Coordination Between Police, Banks and Telecom Bodies is Crucial in Cyber Fraud || Kerala HC: Foreign Counsel Cannot Conduct Cross-Examination Before Commissioners || Allahabad HC: Proclaimed Offenders Get Anticipatory Bail Only in Rare and Exceptional Cases || Madras HC: Repeated Intimacy Alone Doesn't Prove Consent; Coercion & Deception Must be Examined || SC: Government Can Revise Royalty under the MMDR Act Despite a Silent Lease Deed || SC: Recovery of a Weapon Alone is Insufficient to Prove Guilt Without Conscious Possession || SC: Section 68 of Evidence Act Does Not Require Attesting Witnesses to Prove Registered Sale Deeds

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :